BACKGROUND: Organizations have invested in disease management programs to improve quality and to reduce costs, but little is known about the labor characteristics and the program costs necessary to implement a program. OBJECTIVE: To examine the labor characteristics and the program costs of a successful diabetes disease management program. STUDY DESIGN: We performed a labor and cost analysis within a randomized controlled trial of a primary care-based diabetes disease management intervention. METHODS:Participants included 217 patients with type 2 diabetes mellitus and poor glycemic control (glycosylated hemoglobin levels, > or = 8.0%). The intervention group received 12 months of intensive management from clinical pharmacists and a diabetes care coordinator who provided education, applied algorithms for medication management, and addressed barriers to care. The control group attended a single session led by pharmacists, followed by usual care from their primary providers. The process outcomes included the number of patient care-related activities, time spent per patient, and number of drug titrations or additions. The program costs were calculated based on Bureau of Labor Statistics wage data using a sensitivity analysis. RESULTS: The disease management team performed a mean of 4.0 care-related activities for a mean of 38.6 minutes per patient per month for intervention patients and performed a mean of 1.1 care-related activities for a mean of 10.7 minutes per patient per month for control patients (P < .001). Intervention patients had a median of 7 drug titrations or additions during the study. The incremental program cost for the intervention was 36.97 dollars (sensitivity analysis, 6.22 dollars-88.56 dollars) per patient per month. CONCLUSION: A successful diabetes disease management program can be integrated into an academic clinic for modest labor and cost.
RCT Entities:
BACKGROUND: Organizations have invested in disease management programs to improve quality and to reduce costs, but little is known about the labor characteristics and the program costs necessary to implement a program. OBJECTIVE: To examine the labor characteristics and the program costs of a successful diabetes disease management program. STUDY DESIGN: We performed a labor and cost analysis within a randomized controlled trial of a primary care-based diabetes disease management intervention. METHODS:Participants included 217 patients with type 2 diabetes mellitus and poor glycemic control (glycosylated hemoglobin levels, > or = 8.0%). The intervention group received 12 months of intensive management from clinical pharmacists and a diabetes care coordinator who provided education, applied algorithms for medication management, and addressed barriers to care. The control group attended a single session led by pharmacists, followed by usual care from their primary providers. The process outcomes included the number of patient care-related activities, time spent per patient, and number of drug titrations or additions. The program costs were calculated based on Bureau of Labor Statistics wage data using a sensitivity analysis. RESULTS: The disease management team performed a mean of 4.0 care-related activities for a mean of 38.6 minutes per patient per month for intervention patients and performed a mean of 1.1 care-related activities for a mean of 10.7 minutes per patient per month for control patients (P < .001). Intervention patients had a median of 7 drug titrations or additions during the study. The incremental program cost for the intervention was 36.97 dollars (sensitivity analysis, 6.22 dollars-88.56 dollars) per patient per month. CONCLUSION: A successful diabetes disease management program can be integrated into an academic clinic for modest labor and cost.
Authors: Daniel E Jonas; Thomas Miller; Shana Ratner; Brooke McGuirt; Carol E Golin; Catherine Grodensky; Emily Sturkie; Jennifer Kinley; Maureen Dale; Michael Pignone Journal: J Healthc Qual Date: 2017 Jan/Feb Impact factor: 1.095
Authors: Richard O White; Darren A DeWalt; Robert M Malone; Chandra Y Osborn; Michael P Pignone; Russell L Rothman Journal: Am J Manag Care Date: 2010-01 Impact factor: 2.229
Authors: Teryl K Nuckols; Elizabeth A McGlynn; John Adams; Julie Lai; Myong-Hyun Go; Joan Keesey; Julia E Aledort Journal: Health Serv Res Date: 2011-04-01 Impact factor: 3.402
Authors: Linda Haas; Melinda Maryniuk; Joni Beck; Carla E Cox; Paulina Duker; Laura Edwards; Edwin B Fisher; Lenita Hanson; Daniel Kent; Leslie Kolb; Sue McLaughlin; Eric Orzeck; John D Piette; Andrew S Rhinehart; Russell Rothman; Sara Sklaroff; Donna Tomky; Gretchen Youssef Journal: Diabetes Care Date: 2012-09-20 Impact factor: 19.112
Authors: Linda Haas; Melinda Maryniuk; Joni Beck; Carla E Cox; Paulina Duker; Laura Edwards; Edwin B Fisher; Lenita Hanson; Daniel Kent; Leslie Kolb; Sue McLaughlin; Eric Orzeck; John D Piette; Andrew S Rhinehart; Russell Rothman; Sara Sklaroff; Donna Tomky; Gretchen Youssef Journal: Diabetes Care Date: 2013-01 Impact factor: 19.112